← Back to news

G

Google Business, RSS Feed

‘An Overreaction’: Top Investor Isn’t Fazed by Amazon’s Huge CapEx Plans - TipRanks

Why Is Palantir Stock Gaining Monday? - Benzinga

Big Tech’s $660 Billion AI Buildout Could Mean More Debt and Limited Cash Flow for GOOGL, AMZN, and META - TipRanks

US is dependent on European tech too, chips bosses warn - politico.eu

Apple Says These 7 U.S. States Plan to Offer iPhone Driver's Licenses - MacRumors

AI Stocks Turn Choppy. Hyperscaler Capex Explodes. Software Hammered. - Investor's Business Daily

Blue Owl Founders Pledged $1.9 Billion Stake Before Stock Plunge - bloomberg.com

US dollar slammed lower even as data shows the shorts piling in - investingLive

Transocean to Acquire Valaris in $5.8 Billion Deal - The Wall Street Journal

Oracle Stock Rallies After Analyst Upgrades To Buy, Says Sell-Off 'Overshot' - Investor's Business Daily

New Mexico lawsuit accuses Meta of failing to protect children from sexual exploitation online - AP News

Alphabet Looks to Raise About $15 Billion From US Bond Sale - bloomberg.com

Outdoor sportswear pioneer Eddie Bauer again files for bankruptcy - Yahoo Finance

Discord will require a face scan or ID for full access next month - theverge.com

Workday Stock Falls Amid CEO Change. Co-Founder Bhusri Returns To Lead Software Maker. - Investor's Business Daily

Apollo Nears $3 Billion Chip-Funding Deal Tied to XAI - The Information

Novo Says It’s Suing Hims to Halt Obesity Drug Copycats - Bloomberg.com

Alphabet looks to raise about $15 billion from US bond sale, Bloomberg News reports - Reuters

Average Length of US Home Ownership Hits a 25-Year High - Newser

The Toyota Highlander Just Went Electric - InsideEVs

U.S. Stock Futures Trend Lower Ahead of CPI and Jobs Reports - TipRanks

French central bank governor to step down early - Financial Times

Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena - Fierce Biotech

Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter - Workday

Ondas' 4M Defense Secures $30 Million Multi-Year Demining Program in Israel - Ondas Holdings

Kyndryl Shares Halved Amid CFO Departure, Accounting Review - The Wall Street Journal

Kroger Names Ex-Walmart Executive as Its Next CEO - The Wall Street Journal

Commander Shake-Up Speculation Drives Up Banlist Card Prices - Draftsim

Kyndryl’s stock tumbles more than 50%. Here’s what’s gone wrong at the IT provider. - MarketWatch

AI Doesn’t Reduce Work—It Intensifies It - Harvard Business Review

Lilly Strikes Deal for Biotech Orna Worth Up to $2.4 Billion - bloomberg.com

Google Signs Data Center Solar Energy Deals With This Unexpected Partner - Investor's Business Daily

Coca-Cola Earnings Today – Should You Buy KO Stock Ahead of Q4? - TipRanks

BeyondTrust warns of critical RCE flaw in remote support software - BleepingComputer

Hamptons real estate prices hit record, with 2026 summer rentals going fast - CNBC

Biotech doubles financing in quest to silence genes behind neurological diseases - statnews.com

Takeda, Iambic sign AI drug discovery deal with up to $1.7B in milestones - Endpoints News

Ferrari’s New Jony Ive–Designed EV Is Swathed in Glass and Aluminum - WIRED

Electric Ferrari Luce’s Interior Revealed: When Apple Meets Ferrari - The Drive

Transocean to buy Valaris for $5.8 billion, expanding global offshore rig fleet - Reuters

Map shows how almost 100 private jets departed the Bay Area within 2 hours of the Super Bowl ending - Business Insider

Bank of France chief’s surprise exit stokes suspicion among Macron’s opponents - politico.eu

Should You Forget Tesla and Buy These 2 Artificial Intelligence (AI) Stocks Right Now? - The Motley Fool

Meet New-Collar Jobs: The High-Paying Remote Roles You Can Pivot to Without Starting Over - The Everygirl

Goldman Says Hedge Funds Add Record Shorts on US Stocks in Rout - bloomberg.com

Alphabet Is Selling 100-Year Debt as Part of a Big Bond Sale - The Wall Street Journal

Kyndryl reports Q3 earnings for fiscal 2026 - Kyndryl

Lilly to acquire Orna Therapeutics to advance cell therapies - Eli Lilly

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections - CNBC